Global use of antibiotics is surging according to Princeton University researchers who have conducted a broad assessment of antibiotic consumption around the world. The study, "Global Trends in Antibiotic Consumption, 2000-2010," found that worldwide antibiotic use has risen a staggering 36 percent over those 10 years, with five countries — Brazil, Russia, India, China and South Africa (BRICS)— responsible for more than three-quarters of that surge, according to study auth
In the New York Times Ramanan Laxminarayan discusses the urgent need for a global agreement to manage antibiotic effectiveness as a global public good.
Ramanan Laxminarayan spearheads Lancet Infectious Diseases Commission report on global solution to antibiotic resistance including the impact on the environment.
Infection with Klebsiella pneumoniae is a serious danger to older hospitalized patients, with an estimated mortality rate as high as 40 percent. It has generally been treated with broad-spectrum cephalosporin antibiotics. Another class of antibiotics, carbapenems, is used as an antibiotic of last resort for the most persistent infections.
Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States
In this study, we examine trends in the resistance of clinical K. pneumoniae isolates from acute care, long-term care, and outpatient settings across different US geographic regions. Using nationally representative surveillance data that encompass a longer time span and larger isolate count than has been used to date, we characterize the epidemiology of third-generation cephalosporin–resistant and carbapenem-resistant phenotypes of K. pneumoniae between 1999 and 2010. Results are stratified by
"Coca-Cola" Model for Delivering Malaria Meds is a Success, Should be Continued, Say Public Health Experts
A controversial program that uses the private market to provide affordable malaria treatments to people in Africa has dramatically increased access to care and should be continued, says Ramanan Laxminarayan.
Bacteria - including the MRSA superbug -may be more resistant to our most powerful antibiotics after a winter spurt of prescriptions, says a new study.
A new study published in Clinical Infectious Diseases and available online shows how seasonal changes in outpatient antibiotic use – retail sales of antibiotics typically get a boost during the winter – can significantly alter seasonal patterns of drug resistance.
The class focuses on the dynamics of vaccination against infections and the spread of antibiotic-resistant pathogens.
PEI is pleased to announce the appointment of Ramanan Laxminarayan to Research Scholar in the Princeton Environmental Institute.